Key result
A nurse specialist anticoagulant service was as effective as a consultant service in maintaining therapeutic INR control and better at documenting clinical details and reducing interacting drugs.
Why the study?
Does a nurse specialist anticoagulant service improve time in therapeutic INR range and clinical management compared to a consultant anticoagulant service in patients requiring anticoagulation?
Observational
Does a nurse specialist anticoagulant service improve time in therapeutic INR range and clinical management compared to a consultant anticoagulant service in patients requiring anticoagulation?
A nurse-led anticoagulant service is as effective as a consultant-led service for maintaining INR control and superior for clinical documentation, reducing interacting medications, and patient education.
Answers are grounded in this paper and cite their sources.
May support nurse specialist anticoagulation services; leaves open confirmation in randomized trials.
Safe levels of anticoagulation are normally considered to be achieved if patients are maintained within their therapeutic international normalized ratio (INR) range for 70% or more time, but evidence in the United Kingdom suggests that this is often not attained. Recently, alternative models in the management of out-patient anticoagulation have been investigated with favourable results. We report on a study which compared a consultant anticoagulant service (CAS) with a nurse specialist service (NSAS). A sequential design was used with data collected on the consultant run service (CAS), followed by similar data on a NSAS over two 6 month periods. Two patient groups were recruited: those newly referred (group A) and those on long-term treatment (group B). Outcomes were the proportion of time patients spent within INR range, documentation of relevant clinical details, number of drugs taken which may adversely interact with and/or inhibit haemostatic function and patient knowledge. The results indicate that the NSAS was as good as the CAS in maintaining therapeutic control and better at documenting relevant clinical details in reducing the number of drugs taken which may adversely interact with and/or inhibit haemostatic function and in improving some aspects of patient knowledge.
No takes yet. Share an insight, caveat, or question.
Taylor et al. (1997) conducted an observational in Anticoagulation. Nurse specialist anticoagulant service (NSAS) vs. Consultant anticoagulant service (CAS) was evaluated on Proportion of time spent within therapeutic INR range, documentation of clinical details, number of interacting drugs, and patient knowledge. A nurse specialist anticoagulant service was as effective as a consultant service in maintaining therapeutic INR control and better at documenting clinical details and reducing interacting drugs.
Synapse has enriched 10 related papers. Consider them for comparative context: